Extension Study to Evaluate the Post-Treatment Safety and Duration of Clinical Effect of LIPO-202

Clinical trial NCT02483533 · TERMINATED

Trial details

NCT number: NCT02483533
Sponsor: Evofem Inc.
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Central Abdominal Bulging

Start date: 2015-06-01
Primary completion: 2015-12-23
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.